Aravive (Nasdaq: ARAV)
A first-in-class biologic drug, an AXL-Fc fusion protein which acts as a trap for Gas6 AXL signaling which plays an important role tumor metastasis and associated EMT mechanism.
A first-in-class biologic drug targeting an important innate immunity pathway, CD24 Siglec signaling.
C4 Therapeutics (Nasdaq: CCCC)
C4T is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell.
Cognition Therapeutics (Nasdaq: CGTX)
TREATING CENTRAL NERVOUS SYSTEM DISORDERS by targeting the cellular damage response mechanisms
OncoC4 is a clinical stage immuno-oncology company founded by prominent immunologist Prof. Yang Liu. Company develops Best-in-class CTLA-4 antibody and First-in-class CD24 antibody.
A first-in-class small molecule drug targeting LAT1, large amino acid transporter protein.
Next Generation ”Gene-Therapy” Drug Delivery Platform, initially targeting chronic eye diseases, expandable to other broader indications.
To utilize our revolutionary and proprietary targeted protein degradation technology to create, in a highly efficient manner, new drugs for treatment of diseases that currently lack effective therapies.
SHANTON is a biotechnology research organization established in 2016 and key areas of interest focus on uric acid metabolism, inflammatory pain, and gout metabolic syndrome diseases.
At the core of Rapafusyn’s platform are its proprietary diverse libraries of FKBP-binding bi-functional macrocycles (rapafucins).
Translate Condensate Biology into Breakthrough Medicine
A private pharmaceutical company with a therapeutic focus on dermatology, founded in 2021 through a spin-off from Novaliq GmbH.
Restoring Brain Health Harnessing common disease mechanisms to create breakthrough small molecule therapeutics
Develop a cure for ADPKD patients
The Ferroptosis Company
Targeting intersections for precision immunotherapy especially in antigen presentation
A transformative new flow cytometer platform company, replacing traditional filter with optical grating, and PMT with APD.
Twist (Nasdaq: TWST)
Revolutionary silicon-based platform to enable high-throughput, rapid, precise and cost-effective DNA synthesis, potentially applicable in broad fields including healthcare, industrial chemicals, agriculture.
Born out of Harvard Medical School and MIT McGovern Institute for Brain Research, Neural Galaxy aims to help solve one of the biggest challenges facing mankind: brain disorders.
Super-resolution microscopic imaging platform from the Nobel Prize winner’s laboratory
Innovative Ocular Therapeutics for China and Global Markets
Advance personalized health management through precision measurements and technology innovation, to become the guardian of human well-being.
A revolutionary new biosensor platform that supports non-invasive continuous blood chemistry monitoring, including O2, Glucose, PH, lactate etc.
The world leader in the next generation of semiconductor ultrasound technology. Its MEMS-based CMUT technology achieves a higher resolution while significantly reducing the cost.
Disruptive digital Elisa protein-detection platform with ultra-high sensitivity, throughput and dynamic range.
The first AI solutions, FDA cleared for medical imaging enhancement Faster, Safer, Smarter
A platform company aiming to prevent blindness due to Glaucoma and address the biggest challenges in Glaucoma management.
MID IR FIBER LASER MEDICAL AESTHETIC PLATFORM